Explore
Validate
Learn26367-1-AP
antibody from Proteintech Group
Targeting: RBCK1
C20orf18, HOIL1, RBCK2, RNF54, UBCE7IP3, XAP4, ZRANB4
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26367-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- RBCK1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated RBCK1 antibody (Cat. #26367-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, IP,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis.
Mechanistic insights into the homo-dimerization of HOIL-1L and SHARPIN.
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1.
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.
Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China.
A novel inhibitor of nuclear factor kappa-B kinase subunit gamma mutation identified in an incontinentia pigmenti patient with syndromic tooth agenesis.
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Wang Y, Peng M, Zhong Y, Xiong W, Zhu L, Jin X
Oncogene 2023 Mar;42(13):952-966
Oncogene 2023 Mar;42(13):952-966
Mechanistic insights into the homo-dimerization of HOIL-1L and SHARPIN.
Zhang Y, Xu X, Wang Y, Wang Y, Zhou X, Pan L
Biochemical and biophysical research communications 2023 Dec 31;689:149239
Biochemical and biophysical research communications 2023 Dec 31;689:149239
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
Fu L, Bao J, Li J, Li Q, Lin H, Zhou Y, Li J, Yan Y, Langston ME, Sun T, Guo S, Zhou X, Chen Y, Liu Y, Zhao Y, Lu J, Huang Y, Chen W, Chung BI, Luo J
Frontiers in immunology 2022;13:1021935
Frontiers in immunology 2022;13:1021935
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Li Z, Su P, Ding Y, Gao H, Yang H, Li X, Yang X, Xia Y, Zhang C, Fu M, Wang D, Zhang Y, Zhuo S, Zhu J, Zhuang T
Cell communication and signaling : CCS 2022 Oct 24;20(1):164
Cell communication and signaling : CCS 2022 Oct 24;20(1):164
Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1.
Wang G, Zhuang Z, Shen S, Yang F, Jiang Z, Liu Z, Wang T, Hua L
Human cell 2022 May;35(3):896-908
Human cell 2022 May;35(3):896-908
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.
Niu Z, Fan J, Chen F, Yang H, Li X, Zhuang T, Guo C, Cao Q, Zhu J, Wang H, Huang Q
Cell death & disease 2022 Dec 6;13(12):1023
Cell death & disease 2022 Dec 6;13(12):1023
Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China.
Chen L, Wang N, Hu W, Yu X, Yang R, Han Y, Yan Y, Nian N, Sha C
BMC musculoskeletal disorders 2021 Jan 7;22(1):35
BMC musculoskeletal disorders 2021 Jan 7;22(1):35
A novel inhibitor of nuclear factor kappa-B kinase subunit gamma mutation identified in an incontinentia pigmenti patient with syndromic tooth agenesis.
Sun S, Li F, Liu Y, Qu H, Wong SW, Zeng L, Yu M, Feng H, Liu H, Han D
Archives of oral biology 2019 May;101:100-107
Archives of oral biology 2019 May;101:100-107
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Yu S, Dai J, Ma M, Xu T, Kong Y, Cui C, Chi Z, Si L, Tang H, Yang L, Sheng X, Guo J
Cell death & disease 2019 Mar 15;10(4):254
Cell death & disease 2019 Mar 15;10(4):254
No comments: Submit comment
No validations: Submit validation data